RESOURCES

Home / RESOURCES

Resources

March 22, 2019 – Official Launch: British Columbia PharmaCare Lists AbbVie’s Hepatitis C Treatment MAVIRET™

https://www.newswire.ca/news-releases/british-columbia-pharmacare-lists-abbvie-s-hepatitis-c-treatment-maviret-tm-on-its-formulary-821046766.htmlhttps://www.newswire.ca/news-releases/british-columbia-pharmacare-lists-abbvie-s-hepatitis-c-treatment-maviret-tm-on-its-formulary-821046766.html

March 4, 2019 – HCV elimination and the opioid crisis – joint epidemics, joint solutions: results of a pilot program
Julie Holeksa, Tianna Magel & Brian Conway; FUTURE VIROLOGY VOL. 14, NO. 3

https://www.futuremedicine.com/doi/10.2217/fvl-2018-0206

July 17, 2018 – Diagnosis and treatment of hepatitis C virus infection: a tool for engagement with people who inject drugs in Vancouver’s Downtown Eastside
Arshia Alimohammadi, Julie Holeksa, Robyn Parsons, Rossita Yung, Neilofar Amiri, David Truong and Brian Conway
Canadian Liver Journal Volume: 1, Issue: 2, pp. 14-33

https://canlivj.utpjournals.press/doi/full/10.3138/canlivj.1.2.002

May 23, 2018 – Real-world Efficacy of Direct-Acting Antiviral Therapy for HCV Infection Affecting People Who Inject Drugs Delivered in a Multidisciplinary Setting

Arshia Alimohammadi, Julie Holeksa, Astou Thiam, David Truong, Brian Conway
Open Forum Infectious Diseases, Volume 5, Issue 6, 1 June 2018

https://academic.oup.com/ofid/article/5/6/ofy120/5001986?searchresult=1

January 23, 2018 – CADTH Canadian Drug Expert Committee’s recommendation on Glecaprevir/Pibrentasvir (GP)